Table 2.

Biomarker distribution of all samples among all patients (n=113)

Biomarker 2.5th Percentile25th Percentile50th Percentile75th Percentile97.5th Percentile
Albumin1.07×1072.20×1073.42×1076.02×1079.33×107
B2M2.99×1068.30×10612.3×10616.0×10628.7×106
Cystatin C8.60×10437.1×104115×104217×104523×104
EGF4.70×10210.1×10214.2×10220.5×10244.6×102
NGAL3.23×10421.8×10440.9×10491.6×104578×104
OPN1.37×1054.28×1056.36×10513.2×10541.2×105
UMOD3.35×10510.4×10516.6×10523.7×10557.2×105
Clusterin7.27×10417.1×10427.5×10446.8×104152×104
KIM-15.13×10220.1×10234.8×10269.0×102217×102
Osteoactivin6.72×10214.2×10220.0×10227.5×10282 5×102
TFF32.08×1037.06×10312.3×10321.3×10366.6×103
VEGF5.87×1029.39×10213.9×10222.7×10266.4×102
Calbindin3.11×1036.29×1038.72×10316.2×10347.5×103
α-GST0.12×1021.17×1023.03×10211.3×102496×102
  • Values are expressed as pg/ml. B2M, β2-microglobulin; EGF, epithelial growth factor; NGAL, neutrophil gelatinase-associated lipocalin; OPN, osteopontin; UMOD, uromodulin; KIM-1, kidney injury molecule 1; TFF3, trefoil factor 3; VEGF, vascular endothelial growth factor; α-GST, α-glutathione-S-transferase.